Review articlePublished 2011
Pharmacokinetic Modifications and Drug-Drug Interactions in Clinical Monitoring of the Elderly: A Short Review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The combination of drugs may be a result of a necessary therapeutic strategy against a single disease or a fortuitous treatment of two or more health disorders. In either case, a consequence of such approach is the increased risk of drug interactions and subsequent adverse effects. For the elderly, the probability of these events is significantly increased compared to other age groups, not only because of combining medications but also agerelated pharmacokinetic (absorption, distribution, biotransformation and excretion processes) alteration. Since the growth rate of the elderly population worldwide is rapidly increasing, clinicians should be extremely cautious of the drugs prescribed to older patients in order to minimize drug interactions and therapeutic failure.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Luis Eduardo M. Quintas”
- BylineArticles whose byline prints “Karla Regina S. Gram”
- BylineArticles whose byline prints “Gabriel Parreiras Estolano da Silveira”
- BylineArticles whose byline prints “Daniele Valentim S. Lopes”
- BylineArticles whose byline prints “Elisa Suzana Carneiro Pôças”
